91Ó°ÊÓ

Busulfan is a chemotherapeutic agent mainly used in the treatment of chronic myelogenous leukemia. It belongs to a class of compounds known as bifunctional alkylating agents. These agents work by creating strong chemical bonds with biological molecules. Busulfan, in particular, is known for targeting DNA within cancer cells, disrupting their ability to multiply and survive. This effect occurs due to busulfan's unique structure - it has two reactive ends capable of forming these bonds, making it powerful in attacking cancer cells.

• Used to treat blood cancers, especially chronic myelogenous leukemia.
• Targets DNA, stopping cancer cell growth.
• Belongs to alkylating agents, specifically bifunctional due to two active sites.

Understanding how busulfan works helps illuminate why it can be effective against certain cancers. By binding to DNA, it effectively disables the cellular machinery needed for cell replication, providing a means to stop cancer growth.

Alkylating agents are a group of chemicals used in cancer treatment. They are named for their ability to add alkyl groups to various molecules. This addition changes the DNA structure, ultimately leading to cellular death or growth arrest. The main target of these agents is the N7 position of the guanine base in DNA.
In the context of busulfan, as a bifunctional alkylating agent, it has two reactive sites that help it form more stable bonds with DNA. This property distinguishes it from monofunctional agents, which only have one site.

• Works by altering DNA to inhibit cell reproduction.
• Employed in chemotherapy, effective against rapidly dividing cells.
• Busulfan is a prime example due to its dual reactive sites.

By altering the DNA structure, these agents can prevent cancer cells from multiplying, leading to cell death and reduced tumor growth. This makes them a critical tool in oncology.

DNA cross-linking is a key mechanism by which alkylating agents like busulfan exert their effects. Cross-linking involves forming a chemical bond between two DNA strands, effectively tying them together. For busulfan, this process involves reactions with the N7 positions of guanine bases.
The mechanism starts with the first guanine reacting to form an initial bond with busulfan, creating a positively charged sulfur intermediate. This charge attracts a second guanine, leading to cross-linking between the two bases.

• Increases DNA rigidity, hindering replication and transcription processes.
• Busulfan causes intrastrand cross-linking at N7 guanine sites.
• Leads to cell cycle arrest and apoptosis in cancer cells.

Cross-linking is particularly effective in cancer treatment, as it can interrupt crucial cellular processes, making it difficult for cancer cells to continue growing and dividing.